英文字典中文字典


英文字典中文字典51ZiDian.com



中文字典辞典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z       







请输入英文单字，中文词皆可：


请选择你想看的字典辞典：
单词字典翻译
Ruddier查看　Ruddier　在百度字典中的解释百度英翻中〔查看〕
Ruddier查看　Ruddier　在Google字典中的解释Google英翻中〔查看〕
Ruddier查看　Ruddier　在Yahoo字典中的解释Yahoo英翻中〔查看〕

安装中文字典英文字典查询工具!


中文字典英文字典工具:
选择颜色:
输入中英文单字

































































英文字典中文字典相关资料:


  • LIBTAYO® (cemiplimab-rwlc) in Advanced NSCLC, BCC, CSCC . . .
    LIBTAYO is a prescription medicine used to treat adults with a type of skin cancer called basal cell carcinoma (BCC) when your BCC cannot be removed by surgery (locally advanced BCC) or when it has spread (metastatic BCC) and have previously received treatment with a hedgehog pathway inhibitor (HHI), or cannot receive treatment with a HHI
  • Libtayo: Uses, Side Effects, Warnings - Drugs. com
    Libtayo (cemiplimab-rwlc) is used to treat metastatic cutaneous squamous cell carcinoma, basal cell carcinoma, and non-small cell lung cancer Includes Libtayo side effects, interactions and indications
  • LIBTAYO® (cemiplimab-rwlc) | Official HCP Website
    LIBTAYO® (cemiplimab-rwlc) is a prescription medicine indicated for the treatment of adult patients with advanced NSCLC, CSCC, BCC, and as an adjuvant treatment for high-risk CSCC See Important Safety full Prescribing Information
  • LIBTAYO® Full Prescribing Information | Regeneron
    1 3 Non-Small Cell Lung Cancer LIBTAYO in combination with platinum-based chemotherapy is indicated for the first-line treatment of adult patients with non-small cell lung cancer (NSCLC) with no EGFR, ALK or ROS1 aberrations and is:
  • What Is Libtayo Used For in Skin and Lung Cancer - Biology . . .
    Libtayo is an immunotherapy drug approved for certain skin and lung cancers Learn how it works, what conditions it treats, and what to expect during treatment
  • Cemiplimab-rwlc (Libtayo) Updates 2025: Uses in cancer, Side . . .
    This article is about Cemiplimab-rwlc (Libtayo), its uses, side effects, dosage, and what to expect during treatment
  • Cemiplimab (Libtayo Regeneron) - Guidelines+ Monographs
    Libtayo is a programmed death receptor-1 (PD-1) blocking antibody indicated for the treatment of patients with metastatic cutaneous squamous cell carcinoma (mCSCC), locally advanced or metastatic basal cell carcinoma (laBCC or mBCC), and non-small cell lung cancer (NSCLC) It was initially approved in 2018
  • Cemiplimab-rwlc (Libtayo®) - OncoLink
    Cemiplimab-rwlc is a type of monoclonal antibody therapy, which works to stimulate the immune system to destroy cancer cells Cemiplimab-rwlc works as a form of immunotherapy by binding to the “programmed death receptor” (PD1) found on T-cells to stimulate the immune system to find and kill cancer cells
  • Definition of Libtayo - NCI Dictionary of Cancer Terms
    A drug that binds to the protein PD-1 to help immune cells kill cancer cells better and is used to treat different types of cancer Libtayo is used to treat certain types of basal cell carcinoma and cutaneous squamous cell carcinoma (types of skin cancer) that are locally advanced or have spread to other parts of the body
  • Libtayo (cemiplimab): Uses, Side Effects, Dosage Reviews
    Libtayo (cemiplimab or cemiplimab-rwlc) is an immunotherapy medication that’s used to treat certain types of skin cancer and non-small cell lung cancer (NSCLC) It turns on your immune system to attack and kill cancer cells But as a result, it can sometimes cause side effects like rash, diarrhea, and lung problems, which might require special treatment with corticosteroids Libtayo





中文字典-英文字典  2005-2009